This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Side effects

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The side effects of Simvastatin and Pravastatin are described. These include:

  • about 7% of patients experience gastro-intestinal side effects, e.g. abdominal pain, constipation and flatulence

  • less frequently, headache and musculoskeletal symptoms

  • changed biochemical profiles - increased liver transaminases (aspartate aminotransferase or alanine transferase) and levels of the muscle enzyme creatine kinase

  • myositis (muscle pain plus an increase in CK greater than 10 times the upper limit of normal) occurs in less than 0.2% of patients receiving simvastatin

  • rhabdomyolysis:
    • with resultant renal damage
    • a rare side effect of simvastatin
    • often the result of a drug interaction with cyclosporin A, gemfibrozil or nicotinic acid

The adverse effects profile for all statins are similar. Check the summary of products characteristics before prescribing a particular statin.

Reference:

  • Thompson GR. Adverse reactions profile:simvastatin and pravastatin. Prescriber's journal 1993;33(5):217-20.
  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344, 1383-89
  • Horton, R. Reversing risk in coronary disease. Lancet 1998; 344:1497-8.
  • Factfile (6/98). British Heart Foundation.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.